DK193585D0 - Kit til brug ved behandling og forebyggelse af osteoporosis - Google Patents

Kit til brug ved behandling og forebyggelse af osteoporosis

Info

Publication number
DK193585D0
DK193585D0 DK193585A DK193585A DK193585D0 DK 193585 D0 DK193585 D0 DK 193585D0 DK 193585 A DK193585 A DK 193585A DK 193585 A DK193585 A DK 193585A DK 193585 D0 DK193585 D0 DK 193585D0
Authority
DK
Denmark
Prior art keywords
osteoporosis
prevention
treatment
regimen
daily doses
Prior art date
Application number
DK193585A
Other languages
English (en)
Other versions
DK193585A (da
DK173735B1 (da
Inventor
Vernon Albert Uchtman
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of DK193585D0 publication Critical patent/DK193585D0/da
Publication of DK193585A publication Critical patent/DK193585A/da
Application granted granted Critical
Publication of DK173735B1 publication Critical patent/DK173735B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Respiratory Apparatuses And Protective Means (AREA)
  • Surgical Instruments (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Debugging And Monitoring (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
  • Processing Of Solid Wastes (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK198501935A 1984-04-30 1985-04-30 Anvendelse af en knoglecelleaktiverende forbindelse og et knogleresorptionshæmmende polyphosphonat samt eventuelt en placeboforbindelse eller et næringssubstrat .......... DK173735B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US60554084A 1984-04-30 1984-04-30
US60554084 1984-04-30
US68456084A 1984-12-21 1984-12-21
US68456084 1984-12-21

Publications (3)

Publication Number Publication Date
DK193585D0 true DK193585D0 (da) 1985-04-30
DK193585A DK193585A (da) 1985-10-31
DK173735B1 DK173735B1 (da) 2001-08-20

Family

ID=27084976

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198501935A DK173735B1 (da) 1984-04-30 1985-04-30 Anvendelse af en knoglecelleaktiverende forbindelse og et knogleresorptionshæmmende polyphosphonat samt eventuelt en placeboforbindelse eller et næringssubstrat ..........

Country Status (12)

Country Link
EP (2) EP0162510B1 (da)
JP (1) JPH0655675B2 (da)
AT (2) ATE114473T1 (da)
AU (1) AU584611B2 (da)
CA (1) CA1277233C (da)
DE (2) DE3583887D1 (da)
DK (1) DK173735B1 (da)
FI (1) FI851686L (da)
HK (1) HK46694A (da)
IE (1) IE66497B1 (da)
NZ (1) NZ211925A (da)
PH (1) PH22622A (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU568433B2 (en) * 1984-04-30 1987-12-24 Procter & Gamble Company, The Treating osteoporosis
AU569391B2 (en) * 1984-04-30 1988-01-28 Procter & Gamble Company, The Treating osteoporosis
ES8802468A1 (es) * 1985-05-02 1988-07-16 Research Corp Metodo de preparar medicamentos que incluyen un agente buscador de hueso y un inhibidor de anhidrasa carbonica, para impedir y curar enfermedades oseas.
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
CA2035179C (en) * 1990-01-31 2001-08-14 Gerald S. Brenner Pharmaceutical compositions containing insoluble salts of bisphosphonic acids
AU664368B2 (en) * 1991-02-26 1995-11-16 Norwich Eaton Pharmaceuticals, Inc. Methods for the treatment of osteoporosis
EP0550385A1 (de) * 1991-12-19 1993-07-07 Ciba-Geigy Ag Peroral zu verabreichende pharmazeutische Zusammensetzungen, die Methandiphosphonsäure-Derivate und 18-Krone-6 Ether enthalten
US5409911A (en) * 1992-09-11 1995-04-25 Merck & Co., Inc. Prostaglandin analog for treating osteoporosis
US20010007863A1 (en) * 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
WO1996007417A1 (en) * 1994-09-09 1996-03-14 The Procter & Gamble Company Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone
FR2727629A1 (fr) * 1994-12-06 1996-06-07 Sanofi Sa Trousse pour cycle de traitement de l'osteoporose
JP3796693B2 (ja) * 1994-12-28 2006-07-12 ガドール エス アー オルパドロネートからなる骨塊同化組成物
IL120270A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to treat osteoporosis
HN1996000101A (es) 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
DE19629816A1 (de) * 1996-07-24 1998-01-29 Hoechst Ag Neue Cycloalkyl-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
DE19629817A1 (de) * 1996-07-24 1998-01-29 Hoechst Ag Neue Imino-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
DE19653647A1 (de) * 1996-12-20 1998-06-25 Hoechst Ag Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung
AR013994A1 (es) * 1998-10-30 2001-01-31 Gador Sa Procedimiento y preparaciones que modulan selectivamente la funcion del osteoblasto para la prevencion y tratamiento de las osteopatias fragilizantes.
WO2000028982A2 (en) * 1998-11-19 2000-05-25 The Board Of Trustees For The University Of Arkansas Increasing bone strength with selected bisphosphonates
US6121253A (en) * 1998-11-20 2000-09-19 Merck Frosst Canada & Co. Prostaglandin conjugates for treating or preventing bone disease
JP2002538122A (ja) * 1999-03-05 2002-11-12 ザ プロクター アンド ギャンブル カンパニー 天然に存在しないｆｐ選択的アゴニストおよび骨吸収抑制化合物を用いる骨体積の増加方法
MXPA02012682A (es) 2000-06-20 2003-04-25 Novartis Ag Metodo para administrar bisfosfonatos.
AU2000274801A1 (en) * 2000-09-13 2002-03-26 The Procter And Gamble Company Cosmetic method for treatment of skin and/or hair
US20030080191A1 (en) 2001-10-26 2003-05-01 Allen Lubow Method and apparatus for applying bar code information to products during production
WO2003052681A1 (en) 2001-12-17 2003-06-26 International Barcode Corporation Double-sided bar code doubling as a single bar code
EP3345607B1 (en) 2006-12-29 2022-10-26 Ossifi-Mab LLC Methods of altering bone growth by administration of sost or wise antagonist or agonist

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3683080A (en) * 1970-08-28 1972-08-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US4230700A (en) * 1977-12-07 1980-10-28 The Procter & Gamble Company Methods for inhibiting mobilization of calcium phosphate in animal tissue
US4330537A (en) * 1977-12-07 1982-05-18 The Procter & Gamble Company Compositions for inhibiting mobilization of calcium phosphate in animal tissue
AU568433B2 (en) * 1984-04-30 1987-12-24 Procter & Gamble Company, The Treating osteoporosis
AU569391B2 (en) * 1984-04-30 1988-01-28 Procter & Gamble Company, The Treating osteoporosis

Also Published As

Publication number Publication date
DK193585A (da) 1985-10-31
DK173735B1 (da) 2001-08-20
NZ211925A (en) 1989-01-06
DE3587956T2 (de) 1995-05-24
IE851084L (en) 1985-10-30
EP0162510B1 (en) 1991-08-28
EP0381296A1 (en) 1990-08-08
FI851686A7 (fi) 1985-10-31
AU584611B2 (en) 1989-06-01
ATE114473T1 (de) 1994-12-15
FI851686L (fi) 1985-10-31
DE3587956D1 (de) 1995-01-12
EP0381296B1 (en) 1994-11-30
DE3583887D1 (de) 1991-10-02
PH22622A (en) 1988-10-28
JPH0655675B2 (ja) 1994-07-27
EP0162510A1 (en) 1985-11-27
HK46694A (en) 1994-05-20
FI851686A0 (fi) 1985-04-29
JPS6133117A (ja) 1986-02-17
IE66497B1 (en) 1996-01-10
AU4176985A (en) 1985-11-07
CA1277233C (en) 1990-12-04
ATE66608T1 (de) 1991-09-15

Similar Documents

Publication Publication Date Title
DK193585A (da) Kit til brug ved behandling og forebyggelse af osteoporosis
AU598533B2 (en) Synergistic combination of amantadine and selegiline
MX9405383A (es) Imidazo(4,5-c) piridin-4-aminas.
ES522918A0 (es) Procedimiento y aparato para el analisis de compuestos terapeuticos. otrosi.- se hace constar que el procedimiento y aparato que se reivindican en esta patente son inseparables y constituyen un solo objeto.
NO983266L (no) Distribuert Behandling
ES2000880A6 (es) Un procedimiento para preparar n-(1(s)-etoxicarbonil-3-fenilpropil)-l-alanil-l-prolina
ATE25926T1 (de) Dentales restorationsmaterial.
DE69530403D1 (de) Analogen des keratinozytenwachstumfaktors
ES8801243A1 (es) Procedimiento para la obtencion de medicamentos que contienen 1-heteroaril-4--aril-pirazolin-5-onas.
MX9602442A (es) Un tratamiento con fluoroquinolona a dosis unica elevada.
EP0295044A3 (en) Photoinitiator and photopolymerizable composition using the same
IT1203340B (it) Procedimento per fabbricare un manicotto di valvola del tipo in un solo pezzo
ES2063876T3 (es) Transformador piezoceramico.
ZA923935B (en) New 2-amino-5-cyano-1,4-dihydropyridines,processes for their preparation and their use in medicaments
ES8404693A1 (es) Procedimiento de preparacion de nuevos amino-14 esteroides.
UA43337C2 (uk) Гормональний засіб для лікування вугрів
DE3685177D1 (de) Pharmazeutische zubereitung zur behandlung des bluthochdrucks.
AU581736B2 (en) Fungicides and plant-growth controlling agents
GR74351B (da)
NO953477L (no) Gjenbrukbar, höypolig stikkontakt
DK288786D0 (da) Anvendelse af tergurid som geriatrikum
AU8159882A (en) Analgesic potentiation of zomepirac with butorphanol
MY102847A (en) Contrast enhancement layer compositions, alkylnitrones, and use.
JPS5349478A (en) Swimming pacemaker
EP0224924A3 (en) Non-aromatic fluorallylamine mao inhibitors non-aromatic fluorallylamine mao inhibitors

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK